Literature DB >> 9075058

Clinical trials in sepsis: where do we stand?

J L Vincent1.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9075058     DOI： 10.1016/s0883-9441(97)90019-8

Source DB:  PubMed          Journal:  J Crit Care        ISSN： 0883-9441            Impact factor:   3.425


× No keyword cloud information.
  2 in total

1.  Hypothesis: is a failure to prevent bacteriolysis and the synergy among microbial and host-derived pro-inflammatory agonists the main contributory factors to the pathogenesis of post-infectious sequelae?

Authors:  I Ginsburg
Journal:  Inflammation       Date:  2001-02       Impact factor: 4.092

2.  Multi-drug strategies are necessary to inhibit the synergistic mechanism causing tissue damage and organ failure in post infectious sequelae.

Authors:  I Ginsburg
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 5.093
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.